Progresses in cancer vaccine research

Can't see this email? View it online

	June 5, 2019
	Cervical Cancer
	The latest cervical cancer news from News Medical

Progresses in cancer vaccine research

Cancer vaccines are either preventive or therapeutic. Human papilloma virus (HPV) vaccination is a well-known preventative that works against the virus, which may play a role in the onset of cervical carcinomas. On the other hand, a cancer vaccine used in the therapy of prostate cancer has recently been approved. The research is developing and characterizing more and more such vaccines, with the use of microplate readers becoming common place.

			HPV Vaccination and Autoimmune Disorders: Is There a Link? Human papillomavirus (HPV) is a group of viruses that are usually transmitted through sexual contact. There are at least 100 types of this virus, of which around 14 are high-risk types that have been linked to cervical cancer.

			Urine testing just as good as smear test in preventing cervical cancer Urine testing may be as effective as the smear test at preventing cervical cancer, according to new research by University of Manchester scientists.

			New study finds that screening could help prevent rare types of cervical cancer Rare types of cervical cancer can be effectively prevented with screening, a comprehensive study of identified cases of rare cervical cancer over a ten-year period in Sweden concludes. The study was conducted by researchers at Karolinska Institutet and is published in The BMJ.

	New immune-based therapy eliminates HPV in one-third of women with cervical precancerous lesions A potential new immune-based therapy to treat precancers in the cervix completely eliminated both the lesion and the underlying HPV infection in a third of women enrolled in a clinical trial.

	Women in low- and middle-income countries need radiotherapy to treat their cervical cancer A first of its kind study is reporting that millions of women in low- and middle-income countries will need life-saving radiotherapy to treat their cervical cancer, despite the growth of essential human papilloma virus vaccination prevention programs.

	Researchers identify metabolic signatures to help diagnose, treat and prevent cervical cancer Researchers at the University of Arizona have completed the first-of-its-kind study that could aid in the treatment, diagnosis and prevention of cervical cancer by identifying cervicovaginal metabolic signatures, or "fingerprints" that distinguish patients with HPV, pre-cancerous cervical conditions and cancer.

	Cervical cancer subtype increasing in several subpopulations of women A new study reports that a type of cervical cancer that is less amenable to Pap testing is increasing in several subpopulations of women, pointing to the growing importance of human papillomavirus (HPV) testing and vaccination.

Website: www.news-medical.net

Email: [email protected]

Telephone: +44 (0)161 457 7150

AZoNetwork UK Ltd.
NEO, 4th Floor
9 Charlotte Street, Manchester
M1 4ET, UK

Why did you receive this email?
You recently requested related information from us and asked to be notified of additional information.

Not interested anymore?
Unsubscribe or
Update Your Newsletter Subscriptions